Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes.

Alexandre JehlChristine Cugnet-AnceauCorinne VigourouxAnne L LegeayStéphane DalleOlivier HarouLucien MarchandOlivier LascolsCyrielle CaussyCharles ThivoletMartine LavilleEmmanuel Disse

Published in: Diabetes care (2019)

AGL is an additional immune-related adverse event of anti-PD-1 therapy that leads to severe insulin resistance-associated complications.

Keyphrases